secwatch.observer — SEC 8-K summary
======================================

Issuer:     Danimer Scientific, Inc. (—)
CIK:        0001779020
Form:       8-K
Filed at:   2024-05-20T23:59:59+00:00
Accession:  0000950170-24-062219
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Danimer CEO Stephen Croskrey to retire by Dec 31, 2024; Richard Hendrix named Chairman
--------------------------------------------------------------------------------

- Croskrey resigns as Chairman effective May 20; remains Director through July 9 annual meeting.
- Richard Hendrix appointed Chairman and Interim Executive Chairman; Executive Committee formed for CEO search.
- Croskrey's compensation unchanged during transition; eligible for 2024 bonus up to 2.5x base salary.
- Outstanding stock options will continue vesting as if Croskrey remained a Director; performance shares forfeited.
- Company will pay COBRA premiums for Croskrey and spouse after retirement until alternate coverage or COBRA ends.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779020/000095017024062219/0000950170-24-062219-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779020/000095017024062219/dnmr-20240520.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-062219

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer